Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Oosterwijk

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|March 5, 2004
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.
Cancer Research|April 10, 1999
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapyM G Steffens, O C Boerman, W J Oyen, et al.
Acta Biomaterialia|August 27, 2017
A theranostic dental pulp capping agent with improved MRI and CT contrast and biological propertiesS Mastrogiacomo, N Güvener, W Dou, et al.
European Urology|July 24, 2003
Rabbit urethra replacement with a defined biomatrix or small intestinal submucosaJ E Nuininga, H van Moerkerk, A Hanssen, et al.
Biomaterials|December 31, 2003
A rabbit model to tissue engineer the bladderJ E Nuininga, H van Moerkerk, A Hanssen, et al.
British Journal of Cancer|August 8, 2006
Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinomaB A C van Dijk, L J Schouten, E Oosterwijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, J C Oosterwijk-Wakka, et al.
International Journal of Cancer|March 10, 2000
Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250K Grabmaier, J L Vissers, M C De Weijert, et al.
British Journal of Cancer|February 16, 2012
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplificationA S Betof, Z N Rabbani, M E Hardee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, P H de Mulder, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|March 5, 2004
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.
Cancer Research|April 10, 1999
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapyM G Steffens, O C Boerman, W J Oyen, et al.
Acta Biomaterialia|August 27, 2017
A theranostic dental pulp capping agent with improved MRI and CT contrast and biological propertiesS Mastrogiacomo, N Güvener, W Dou, et al.
European Urology|July 24, 2003
Rabbit urethra replacement with a defined biomatrix or small intestinal submucosaJ E Nuininga, H van Moerkerk, A Hanssen, et al.
Biomaterials|December 31, 2003
A rabbit model to tissue engineer the bladderJ E Nuininga, H van Moerkerk, A Hanssen, et al.
British Journal of Cancer|August 8, 2006
Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinomaB A C van Dijk, L J Schouten, E Oosterwijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, J C Oosterwijk-Wakka, et al.
International Journal of Cancer|March 10, 2000
Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250K Grabmaier, J L Vissers, M C De Weijert, et al.
British Journal of Cancer|February 16, 2012
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplificationA S Betof, Z N Rabbani, M E Hardee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250M G Steffens, O C Boerman, P H de Mulder, et al.
Pageof 8